StockData
Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc. (PBYI) stock

PBYINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3019% below fair value
$7.05−0.07 (-0.98%)

Close on Nov 20, 2026Market cap $363.92MP/E 13.6Yield –

Puma Biotechnology revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Puma Biotechnology's revenue for the twelve months ending Jun 30, 2026 was $231.24M, down 2.9% year over year. For fiscal 2025 it was $228.37M, down 0.9% from the year before. The highest annual figure on record is $272.26M in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$228.37M-0.9%
FY2024Dec 31, 2024$230.47M-2.2%
FY2023Dec 31, 2023$235.64M+3.3%
FY2022Dec 31, 2022$228.03M-9.9%
FY2021Dec 31, 2021$253.16M+12.5%
FY2020Dec 31, 2020$225.11M-17.3%
FY2019Dec 31, 2019$272.26M+8.5%
FY2018Dec 31, 2018$250.99M+806.6%
FY2017Dec 31, 2017$27.69M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$56.50M+7.8%
Q1 FY2026Mar 31, 2026$44.81M-2.6%
Q4 FY2025Dec 31, 2025$75.45M+27.7%
Q3 FY2025Sep 30, 2025$54.48M-32.4%
Q2 FY2025Jun 30, 2025$52.44M+11.4%
Q1 FY2025Mar 31, 2025$46.01M+5.1%
Q4 FY2024Dec 31, 2024$59.08M-18.2%
Q3 FY2024Sep 30, 2024$80.54M+43.5%
Q2 FY2024Jun 30, 2024$47.08M-13.7%
Q1 FY2024Mar 31, 2024$43.77M-17.1%
Q4 FY2023Dec 31, 2023$72.18M+9.9%
Q3 FY2023Sep 30, 2023$56.12M-1.7%
Q2 FY2023Jun 30, 2023$54.57M-8.3%
Q1 FY2023Mar 31, 2023$52.78M+15.4%
Q4 FY2022Dec 31, 2022$65.68M+18.6%
Q3 FY2022Sep 30, 2022$57.10M+23.5%
Q2 FY2022Jun 30, 2022$59.52M+11.5%
Q1 FY2022Mar 31, 2022$45.74M-53.4%
Q4 FY2021Dec 31, 2021$55.36M+5.3%
Q3 FY2021Sep 30, 2021$46.25M-8.9%
Q2 FY2021Jun 30, 2021$53.38M-24.4%
Q1 FY2021Mar 31, 2021$98.17M+91.7%
Q4 FY2020Dec 31, 2020$52.56M-16.5%
Q3 FY2020Sep 30, 2020$50.75M-9.9%
Q2 FY2020Jun 30, 2020$70.58M+30.9%
Q1 FY2020Mar 31, 2020$51.22M-48.3%
Q4 FY2019Dec 31, 2019$62.92M-11.5%
Q3 FY2019Sep 30, 2019$56.35M-10.0%
Q2 FY2019Jun 30, 2019$53.92M+6.2%
Q1 FY2019Mar 31, 2019$99.07M+48.9%
Q4 FY2018Dec 31, 2018$71.08M+228.9%
Q3 FY2018Sep 30, 2018$62.63M+930.6%
Q2 FY2018Jun 30, 2018$50.77M–
Q1 FY2018Mar 31, 2018$66.52M–
Q4 FY2017Dec 31, 2017$21.61M–
Q3 FY2017Sep 30, 2017$6.08M–

More Puma Biotechnology figures

See a number that looks wrong?